Baldwin Insurance Group Inc Dossier - Source-backed chat

Baldwin Insurance Group Inc

BWINNASDAQ

SectorFinancials

IndustryInsurance Brokers

Beta (adjusted)1.01

Intrinsic Value

Insufficient data for a value estimateNot enough reliable inputs to publish a fair value for this company yet.

Market Price $31.79Price as of 30 Sep 2026

Data confidence Sign in to view data confidence

Market Cap $3.1B

Enterprise Value $4.5B

Shares Outstanding 90.8M diluted

Next Earnings Date3 Nov 2026

All prices and values are periodic snapshots, not live quotes. Source dates are shown for reference.

Thesis

Street consensus, scenarios, merits, risks, and invalidation triggers

AI-assisted

Thesis Summary

The Baldwin Insurance Group, Inc. (NASDAQ: BWIN) represents a compelling investment opportunity in the independent insurance distribution sector. Despite recent stock price pressure and a slight Q1 2026 EPS miss, the company continues to deliver industry-leading top-line growth, driven by strategic partnerships like the CAC Group. Baldwin is executing on its '3B30' objective to reach $3 billion in revenue and a 30% adjusted EBITDA margin by 2029, supported by its AI-driven Catalyst Program. With a significant valuation discount relative to retail peers and a robust $250 million share repurchase program, BWIN offers an attractive risk-reward profile for long-term investors.

This section is the 12-month view: analyst targets and the probability-weighted scenarios built from them. The intrinsic value at the top of this page answers a different question: what the business is worth today.

Street view · analyst 12-month targets9 analysts · as of 18 Aug 2026

Low · most bearish analyst$26.00

Mean target$32.22

High · most bullish analyst$38.00

Our research · scenarios, merits, risks, and invalidation triggersResearch as of 18 Sep 2026

Scenarios · 12-month scenario targetsAnchored at research date

Bear CaseDownside scenario

$26.00

Integration challenges with the CAC Group or other partners lead to higher-than-expected expenses and margin compression. Continued headwinds in the E&S homeowners portfolio and a softening property & casualty pricing cycle limit organic growth. High leverage and debt service obligations restrict financial flexibility, keeping the stock under pressure.

Base CaseCentral scenario

$32.22

Matches the consensus mean

Baldwin successfully integrates its recent acquisitions, achieving targeted expense synergies. Organic growth remains in the high-single to low-double-digit range over the medium term. Adjusted EBITDA margins gradually improve toward 30% over the next 4-5 years, supported by the 3B30 Catalyst program. The stock trades closer to its historical multiples and consensus analyst targets.

Bull CaseUpside scenario

$38.00

Rapid integration of the CAC Group and other partnerships accelerates cross-selling opportunities, while the proprietary AI orchestration layer drives operational efficiencies ahead of schedule. Organic growth reaccelerates to double digits by Q4 2026, and adjusted EBITDA margins expand toward the 30% target faster than anticipated, leading to significant multiple expansion.

Scenarios are anchored to street consensus at the research date, with our probabilities and rationale.

Key Investment Merits

Differentiated, vertically integrated platform spanning distribution, product manufacturing, and risk capital management.
Strong top-line momentum with Q1 2026 total revenue growing 29% year-over-year to $532.2 million.
Clear operational roadmap via the 3B30 Catalyst Program, leveraging AI to drive productivity and margin expansion.
Active capital return program with a $250 million share repurchase authorization ($203 million remaining as of mid-2026).

Key Investment Risks

High level of indebtedness, with consolidated debt exceeding $2.34 billion as of Q1 2026.
Integration risks associated with large-scale acquisitions and partnerships, such as the CAC Group.
Exposure to volatile property insurance markets, particularly coastal E&S homeowners portfolios.
Potential softening of the property & casualty pricing cycle, which could impact commission and fee growth.

Thesis Invalidation Triggers

Organic revenue growth falling to zero or turning negative for consecutive quarters.
Failure to achieve targeted expense synergies from the CAC Group integration, leading to persistent margin compression.
A significant downgrade in credit ratings due to failure to manage leverage and debt service obligations.

All scenarios are estimates and subject to change. Past performance is not indicative of future results.

Quality Pillars Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Explore this dossier

ValuationIntrinsic value, the six-method breakdown, peer medians, and your assumptions sandbox.Financial SnapshotRevenue, profitability, returns, balance sheet, dividends, and the filing-level detail.Qualitative AnalysisBusiness overview, strategic initiatives, and mergers, acquisitions & partnerships.Outlook & Key DatesForward estimates, reporting calendar, and the monitoring framework.